Just - Evotec Biologics
Jeff Meyer is currently serving as the Senior Director of Analytical Sciences and Drug Product Design at Just - Evotec Biologics. Previously, Jeff held various positions at Bristol-Myers Squibb, including Director of ZymoGenetics and Principal Scientist. He has extensive experience in formulation development, analytical development, and leading analytical teams. Jeff holds a PhD in Pharmaceutical Biotechnology from the University of Colorado Anschutz Medical Campus.
Just - Evotec Biologics
1 followers
Just – Evotec Biologics, wholly owned by Evotec SE, is a first-to-industry biologics platform that leverages AI/ML technologies and world-leading molecular design, cell line development, process intensification and continuous manufacturing strategies to advance biotherapeutics from discovery through clinical stages to commercial launch. The Just – Evotec Biologics team combines deep industry experience in the fields of data, protein, process, and manufacturing sciences including automation with highly integrated and flexible capabilities to break through the scientific and economic barriers associated with the development of protein therapeutics. Our focus is to accelerate and expand access to biotherapeutics through scientific and technological innovation for our proprietary projects and on behalf of our partners. Learn more at www.just-evotecbiologics.com